Clinical trial
Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen
NCT02243254 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- Not reported
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperalgesia, ibuprofen, pain, postoperative, remifentanil